Cargando…

Transmission Potential of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in South Korea, 25 November 2021–8 January 2022

Our study indicates sustained transmission (effective reproduction number, 1.3; serial interval, 4.2 days; regional doubling times, 3.3–11.4 days) of the severe acute respiratory syndrome coronavirus 2 Omicron (B.1.1.529) variant (N = 2351) in South Korea (25 November 2021–8 January 2022), implicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Eunha, Choi, Wongyeong, Kwon, Donghyok, Kim, Taeyoung, Song, Youngji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129224/ https://www.ncbi.nlm.nih.gov/pubmed/35855956 http://dx.doi.org/10.1093/ofid/ofac248

Ejemplares similares

Clinical Time Delay Distributions of COVID-19 in 2020–2022 in the Republic of Korea: Inferences from a Nationwide Database Analysis
por: Shim, Eunha, et al.
Publicado: (2022)

First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022
por: Maisa, A., et al.
Publicado: (2022)

Transmission potential and severity of COVID-19 in South Korea
por: Shim, Eunha, et al.
Publicado: (2020)

Proportion of Pre-Symptomatic Transmission Events Associated with COVID-19 in South Korea
por: Song, Youngji, et al.
Publicado: (2022)

Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example
por: Choi, Wongyeong, et al.
Publicado: (2021)

Estimating the Risk of COVID-19 Death during the Course of the Outbreak in Korea, February–May 2020
por: Shim, Eunha, et al.
Publicado: (2020)

Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022
por: Liang, Yuelang, et al.
Publicado: (2022)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

Optimal strategies for vaccination and social distancing in a game-theoretic epidemiologic model
por: Choi, Wongyeong, et al.
Publicado: (2020)

Optimal strategies for social distancing and testing to control COVID-19
por: Choi, Wongyeong, et al.
Publicado: (2021)

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
por: Lee, Ji Joo, et al.
Publicado: (2021)

Dr. Mohammed El Gammal MD 8(th) November 1951–25(th) January 2022
por: Shoaiby, Ali Al
Publicado: (2022)

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
por: Stefanelli, Paola, et al.
Publicado: (2022)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Acknowledgment to reviewers—November 2021 to October 2022
Publicado: (2023)

SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
por: Baker, Julia M., et al.
Publicado: (2022)

Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023)

Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
por: Petrone, Daniele, et al.
Publicado: (2023)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2020–November 2021
por: Sadigh, Katrin S., et al.
Publicado: (2022)

Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021
por: Flechsler, Jennifer, et al.
Publicado: (2022)

Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022
por: Xin, Hualei, et al.
Publicado: (2023)

The pattern of neurocritical disorders in multicenter in Khartoum State November 2020 to January 2021
por: Ali, Khalid Mohamed, et al.
Publicado: (2022)

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022)

Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021
por: Shim, Eunha
Publicado: (2021)

Effectiveness of MRNA booster vaccine among healthcare workers in New York City during the Omicron surge, December 2021 to January 2022
por: Robilotti, Elizabeth V., et al.
Publicado: (2022)

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021
por: Gu, Haogao, et al.
Publicado: (2022)

Reviewers for Journal of Insect Science (November 2021–October 2022)
Publicado: (2023)

Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022
por: Klaassen, Fayette, et al.
Publicado: (2023)

Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022
por: Nduwimana, Cassien, et al.
Publicado: (2023)

Genomic Variability of SARS-CoV-2 Omicron Variant Circulating in the Russian Federation during Early December 2021 and Late January 2022
por: Chernyaeva, Ekaterina N., et al.
Publicado: (2022)

Projection of healthcare demand in Germany and Switzerland urged by Omicron wave (January–March 2022)
por: Gorji, Hossein, et al.
Publicado: (2023)

COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
por: Kim, Christine, et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022
por: Mohamed, Abdinoor, et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022
por: Mbaeyi, Chukwuma, et al.
Publicado: (2022)

Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022
por: Kim, Jong Mu, et al.
Publicado: (2023)

Assessment of the impacts and transmission of coronavirus observed in the Republic of Korea in 2020–2021
por: Chung, Y. S., et al.
Publicado: (2021)

January 2022-December 2022
Publicado: (2022)

Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study
por: Ko, Youngsuk, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3lu0qlgelja0hos1knig5jd6j